| Frame formulation |
|
|
|
| Written by DPR Biocides - Anses |
| Friday, 09 April 2010 14:55 |
A frame formulation must contain the same active substances having the same characteristics, and their composition can only have variations from a previously authorised product, that do not affect the level of risk with which they are associated, or their efficacy. - Regulatory reference texts: Articles R522-24 to R522-25 of the French Environmental Code - Fees payable to ANSES: €2,000
- Regulatory reference texts:
- Notes: A frame formulation must be established in advance and it is necessary to be the holder of this frame formulation or holder of a letter of access to the FF. - Deadlines : 5 months with the possibility of a suspension of the evaluation if additional information is necessary - Validity of the authorisation: 10 years. - Fees payable to ANSES: €1,800 - Composition of the dossier:
The dossier must comply with Article 3 of the Ministerial Order of 19 May 2004 1. Identification of the applicant and manufacturers: 1.1. Name and address of the applicant. 1.2 Names and addresses of the manufacturers of the biocidal product and active substances, including the address of the production facility. 1.3. Where appropriate, a letter of access to the relevant necessary data. 2. Identity of the biocidal product: 2.1. Commercial name. 2.2. Full composition of the biocidal product. 2.3. Physical and chemical properties ensuring proper use, storage and transport of the product. 3. Intended uses: 3.1. Product type and field of use. 3.2. Category of users. 3.3. Method of use. 4. Data on efficacy. 5. Analytical methods. 6. Classification, packaging and labelling, including a draft label, in accordance with the provisions of Article 20 of the abovementioned Decree of 26 February 2004 and Article 10 of the present Ministerial Order. 7. Safety Data Sheet. ( SDS) |
| Last Updated on Friday, 25 March 2011 16:12 |











The European Union offers an